Industry News-Good Doctor

Blog

——

2024.09.26

The National Cancer Center has just released: 2024 National Cancer Report

Recently, with the approval of the National Health Commission, the National Cancer Center released the 2022 burden of malignant tumors in China based on the latest data from tumor registration and follow-up monitoring on JNCC. The results released this time are jointly calculated by the National Cancer Center and the International Agency for Research on Cancer (IARC), consistent with the Chinese data published by IARC in GLOBOCAN 2022 and released simultaneously.

2026.04.20

Good Doctor·Hyperthermic Intrathoracic Chemotherapy | Multidisciplinary Treatment of Malignant Pleural Effusion: HITHOC Is Superior to Traditional Methods in Controlling Effusion

2026.04.13

Good Doctor·Hyperthermic Perfusion | “Elite Pursuit of Excellence” Furnace Program — The 2026 Standardized Spring Training Camp on Body Cavity Hyperthermic Perfusion Therapy (Shanxi Station) Concludes Successfully

“Empowering Clinical Practice, Jointly Driving Development.” Recently, the two-day “Elite Pursuit of Excellence” Melting Pot Program—the 2026 Standardized Spring Training Camp on Intraperitoneal Hyperthermic Perfusion Therapy (Shanxi Station)—concluded successfully in Taiyuan. Clinical experts from the front lines across Shanxi Province gathered to jointly explore and refine techniques, thereby advancing diagnostic and therapeutic practices. This milestone marks a new phase in the standardized promotion of intraperitoneal hyperthermic perfusion therapy (HIPEC) throughout the Shanxi region.

2026.04.10

Reprinted: In-Depth Report on the Cutting Edge of Clinical Research on Peritoneal Metastatic Tumors Worldwide, 2021–2026

Peritoneal metastatic cancer (PM) was once regarded as a “terminal stage of cancer,” but rapid advances in diagnostic and therapeutic technologies are now ushering in a transformative turning point in this field. This review provides an in-depth analysis of cutting-edge developments in the treatment of peritoneal metastatic cancer from 2021 to 2026, with a particular focus on the optimization and innovation of the core strategy of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). It demonstrates how multidisciplinary team (MDT) approaches are reshaping patient outcomes and how precision diagnostics and minimally invasive techniques are bringing new hope to this refractory malignancy.

2026.03.31

Good Doctor·Hyperthermic Perfusion | Commentary on Literature | (1) "Clinical Application of Isothermal Circulating Hyperthermic Perfusion Chemotherapy in the Prevention and Treatment of Cavity Metastatic Cancer"

Guidelines for hyperthermic intraperitoneal chemotherapy (HIPEC) were first published in Europe in 2008 by the European Society of Surgical Oncology (ESSO) and the European Society of Gynaecological Oncology (ESGO), and in the United States in 2014 by the American Society for Peritoneal Surface Malignancies (ASPSM). In China, the CACA guidelines for HIPEC were released in 2023. To date, no guidelines for hyperthermic intrathoracic chemotherapy (HITHOC) have been issued either domestically or internationally. The authors of this article and their team began clinically applying body-cavity hyperthermic perfusion machines to treat 290 patients as early as 2006, successfully completing a total of 1,075 HIPEC or HITHOC procedures. They can thus be regarded as pioneers and trailblazers in this field.

2026.03.03

[Exhibition News] 2026 China Integrated Oncology Conference – November 12–15, Changsha, Hunan Province

The Xiang River flows majestically, and Mount Lu rises grandly—standing at the forefront of integrative medicine; the ancient lands of Xiaoxiang and Shusi, steeped in sacred history, are painting a grand vision for global cancer combat. Embracing the spiritual essence of mountains and waters, we usher in a grand gathering for our times. From November 12 to 15, 2026, the highly anticipated 2026 China Conference on Integrative Oncology (CCHI0) will be held with great splendor in Changsha, the “City of Stars.” This conference is organized by the Chinese Anti-Cancer Association (CACA), co-organized by the International Association for Holistic and Integrative Medicine (IAHIM), the World Association for Integrative Oncology (WAIO), and the Hunan Provincial Anti-Cancer Association, and hosted by the Hunan Provincial Tumor Hospital.

2026.02.28

Reprinted: Expert Consensus on the Comprehensive Diagnosis and Treatment of Peritoneal Metastasis from Appendiceal Epithelial Tumors (2025 Edition)

Appendiceal epithelial tumors refer to neoplastic lesions originating from the mucosal epithelium of the appendix. These tumors exhibit marked heterogeneity in their pathological features and biological behavior. Due to their unique structural and biological characteristics, they have a high propensity for peritoneal metastasis. Currently, there is limited evidence-based medical support for the diagnosis and treatment of appendiceal epithelial tumors and their peritoneal metastases, and clinical practice still lacks unified guidelines. To address this gap, the Specialist Committee on Integrated Rehabilitation for Peritoneal Tumors of the Chinese Anti-Cancer Association has brought together multidisciplinary experts to systematically integrate specialized technical expertise around key aspects including pathological classification and clinical staging of appendiceal epithelial tumors, indications for extended resection following local excision, surgical strategies for managing concurrent peritoneal metastases, perioperative rehabilitation, and personalized treatment approaches. At the same time, the committee has standardized the perioperative management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), as well as the clinical application of prehabilitation protocols, thereby enhancing the practicality and operability of these procedures. Ultimately, the "Expert Consensus on Comprehensive Diagnosis and Treatment of Peritoneal Metastasis from Appendiceal Epithelial Tumors (2025 Edition)" has been developed. This consensus aims to further standardize the systematic diagnostic and therapeutic workflows for appendiceal epithelial tumors, reduce the risk of recurrence, improve patient outcomes, and promote the standardization and homogenization of the diagnosis and treatment of peritoneal metastases from these tumors.

2026.01.22

[Exhibition News] The 29th Annual Academic Conference of the Chinese Society of Clinical Oncology (CSCO), 2026

This conference will continue to uphold the fundamental mission of CSCO, further promoting academic exchanges and scientific-technological cooperation in the fields of clinical oncology both internationally and domestically. It will encourage and support clinical research and innovation, advocate precision oncology based on multidisciplinary, standardized, and comprehensive treatment approaches, and actively advance the development of the discipline.

< 1 2 3 4 > proceed page

· China Good Doctor ·

· Good friends of human beings ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Blog

COOKIES

COOKIES

Sorry，The current column has no content!